or
forgot password

    • cancer clinical trials in flossmoor, IL

    • Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor, Illinois 60422
    Non-small Cell Lung Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor, Illinois 60422
    Advanced Prostate Cancer, Prostatic Neoplasms
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor, Illinois 60422
    Ovarian Neoplasms
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor, Illinois 60422
    Non Small Cell Lung Carcinoma
    STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor, Illinois 60422
    Melanoma
    Non-small Cell Lung Cancer Registry
    Lekha Babu M.D Ltd.
    Flossmoor, Illinois 60422
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor, Illinois 60422
    Myelodysplastic Syndromes
    TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
    Joliet Oncology-Hematology Associates, Inc.
    Flossmoor, Illinois 60422
    Ovarian Neoplasms
    Study of XL999 in Patients With Non-small Cell Lung Cancer
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor, Illinois 60422
    Non-small Cell Lung Cancer
    Study of XL999 in Patients With Multiple Myeloma
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor, Illinois 60422
    Multiple Myeloma
    Ph 3 Randomized Study of Telcyta® + Liposomal Doxorubicin Vs Liposomal Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer
    Joliet Oncology-Hematology Associates, Ltd.

    Trial Locations
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor Cancer Care (JOHA DBA)
    Ovarian Neoplasms
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor, Illinois 60422
    Myelodysplastic Syndrome (MDS)
    Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor, Illinois 60422
    Metastatic Pancreatic Cancer
    Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
    South Suburban Neurology
    Flossmoor, Illinois 60422
    Multiple Sclerosis
    Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
    Joliet Oncology-Hematology Associates, Ltd.
    Flossmoor, Illinois 60422
    Anemia, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small-Cell Lung, Bladder Cancer, Cancer of Head and Neck, Uterine Cervical Cancer